Monod Bio Taps AI Protein Design to Build Rapid Point-of-Care Preeclampsia Test
The Seattle biotech company receives a $750,000 Gates Foundation grant to develop a rapid diagnostic using novel protein binders and a luciferase system.
The Seattle biotech company receives a $750,000 Gates Foundation grant to develop a rapid diagnostic using novel protein binders and a luciferase system.
Researchers are developing a large-scale olfactory dataset to train artificial intelligence, potentially unlocking smell as a powerful tool for early disease detection.
The machine learning-powered platform analyzes gene expression data from biopsies to provide molecular scores for rejection probability and tissue injury.
The multi-year collaboration aims to integrate robotic liquid-handling capabilities with BD single-cell instruments to accelerate disease research and drug development.
OncoGenDx analyzes 335 DNA genes and 72 RNA genes using next-generation sequencing technology to support treatment decisions.